首页|焦虑、抑郁情绪对艾滋病患者抗病毒治疗免疫学失败的影响及心理干预策略分析

焦虑、抑郁情绪对艾滋病患者抗病毒治疗免疫学失败的影响及心理干预策略分析

扫码查看
目的 分析焦虑、抑郁情绪对艾滋病患者抗病毒治疗免疫学失败的影响,并提出相应的心理干预策略.方法 回顾性分析2021年2月至2022年2月北京某医院收治的200例接受抗病毒治疗的艾滋病患者的临床资料,根据抗病毒治疗后的免疫应答情况将其分为成功组和失败组.比较两组的基础资料与治疗前心理状态,统计两组的焦虑自评量表(SAS)、抑郁自评量表(SDS)评分,采用单因素、多因素Logistic回归分析影响艾滋病患者抗病毒治疗免疫学失败的因素,绘制受试者工作特征(ROC)曲线,分析SAS、SDS评分及二者联合预测艾滋病患者抗病毒治疗免疫学应答失败的临床价值.结果 200例艾滋病患者抗病毒治疗后免疫学失败率为21.00%(42/200).失败组性别、年龄、世界卫生组织临床分期、服药依从性及是否合并焦虑、抑郁与成功组比较,差异具有统计学意义(P<0.05);多因素Logistic回归分析结果显示,性别(男)、年龄(≥60岁)、世界卫生组织临床分期(Ⅲ/Ⅳ期)、服药依从性(不依从)、焦虑和抑郁状态是影响艾滋病患者抗病毒治疗免疫学应答失败的危险因素(OR>1,P<0.05).失败组SAS、SDS评分高于成功组(P<0.05);ROC曲线结果显示,SAS、SDS评分及二者联合预测艾滋病患者抗病毒治疗免疫学应答失败的曲线下面积分别为0.734、0.724、0.768.结论 艾滋病患者抗病毒治疗后仍有部分患者出现免疫学失败,原因多与性别、年龄、世界卫生组织临床分期、服药依从性、焦虑与抑郁情绪相关,且SAS评分联合SDS评分可有效预测艾滋病患者抗病毒治疗免疫学应答的失败.
Influence of anxiety and depression on immunological failure of antiviral therapy in acquired immune deficiency syndrome patients and analysis of psychological intervention strategies
Objective To analyze the influence of anxiety and depression on immunological failure of antiviral therapy(ART)in acquired immune deficiency syndrome(AIDS)patients and propose corresponding psychological intervention strategies.Methods The clinical data of 200 AIDS patients admitted to a hospital in Beijing and received antiviral treatment from February 2021 to February 2022 were retrospective analyzed.According to the immune response condition after antiviral treatment,they were divided into success group and failure group.Basic data and pre-treatment psychological state of the two groups were compared.Self-rating anxiety scale(SAS)and self-rating depression scale(SDS)scores of the two groups were counted.Univariate and multivariate Logistic regression was used to analyze the factors affecting the immunological failure of AIDS patients with antiviral therapy,and receiver operating characteristics(ROC)curve was drawn to analyze the clinical value of SAS and SDS scores and their combination in predicting the failure of immunological response to antiviral therapy in AIDS patients.Results The immunological failure rate of 200 AIDS patients after antiviral therapy was 21.00%(42/200).There were significant differences in gender,age,world health organization(WHO)clinical stage,medication compliance and whether anxiety and depression were combined between failure group and successful group(P<0.05).Multivariate Logistic regression analysis showed that gender(male),age(≥60 years old),WHO clinical stage(Ⅲ/Ⅳ),medication compliance(non-compliance),anxiety and depression were the risk factors for the failure of immunological response to antiviral therapy in AIDS patients(OR>1,P<0.05).The SAS and SDS scores in the failure group were higher than those in the success group(P<0.05).The ROC curve showed that the area under curve(AUC)of SAS score,SDS score and the combination of the two in predicting the immunological response failure of AIDS patients to antiviral therapy were 0.734,0.724 and 0.768,respectively.Conclusions Some AIDS patients still have immunological failure after antiviral treatment.The reasons are mainly related to gender,age,WHO clinical stage,medication compliance,anxiety and depression,and SAS score combined SDS score can effectively predict the failure of immunological response to antiviral treatment in AIDS patients.

Acquired immunodeficiency syndromeAntiviral treatmentImmunological failureAnxietyDepression

刘旭、赵杨、谭淑平、刘佳

展开 >

北京回龙观医院医患关系协调办公室,北京 100096

北京回龙观医院精神医学研究中心,北京 100096

艾滋病 抗病毒治疗 免疫学失败 焦虑 抑郁

北京市卫生科技发展专项

2018-4-320

2024

中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
年,卷(期):2024.33(3)
  • 18